Microneedle Patches Enable Copper Peptide GHK-Cu to Penetrate Skin — Going From Zero Absorption to Significant Delivery

Microneedle pretreatment of human skin enabled dramatic GHK-Cu permeation: 134 ± 12 nanomoles of peptide and 705 ± 84 nanomoles of copper crossed the skin in 9 hours, versus essentially zero through intact skin. The depth and percentage of microneedle penetration were directly correlated with application force, which determined the degree of permeability enhancement. Histological assays and confocal microscopy confirmed well-defined channels through the stratum corneum. No skin irritation was observed.

Polymeric microneedle arrays were used to pretreat skin samples before GHK-Cu application. Two in vitro skin permeation models (including human skin) assessed drug delivery. Histological examination and confocal laser scanning microscopy characterized microconduits. Application force was varied to establish force-penetration-permeation relationships. Safety was assessed using keratinocyte cell viability assays and porcine skin irritation models.

GHK-Cu is one of the most well-studied regenerative peptides with demonstrated abilities to stimulate collagen synthesis and accelerate wound healing. However, topical application has been limited by near-zero skin absorption. Microneedle patches offer a practical, painless solution that creates only temporary microchannels healing within hours. This could finally make GHK-Cu an effective topical therapy.

Microneedle technology has exploded in recent years with applications from vaccine delivery to insulin administration. This study applies it to cosmeceutical peptide delivery. The demonstration that microneedles can deliver both the peptide and its copper cofactor simultaneously is particularly practical, as GHK-Cu's activity requires the intact peptide-metal complex. The approach is generalizable to other hydrophilic peptides facing the same skin penetration barrier.

The study used in vitro skin models — actual in vivo absorption may differ due to blood flow and metabolism. The 9-hour permeation window may not reflect practical use patterns. Long-term safety of repeated microneedle use was not assessed. The biological activity of delivered GHK-Cu was not measured, only the quantity that permeated. Clinical efficacy was not tested.